NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDNintedanib  Malignant disease and immunosuppression, Protein kinase inhibitors, 08.01.05
REDNintedanib 100mg, 150mg Ofev®
(Capsules) 		Respiratory system, Antifibrotics , 03.11
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Nintedanib Nintedanib Malignant Disease, Targeted Therapy Responsive Malignancy
Nintedanib Nintedanib Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Nintedanib Nintedanib Respiratory System, Interstitial Lung Disease
Nintedanib Nintedanib Respiratory System, Interstitial Lung Disease, Antineoplastic Drugs Protein Kinase Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1111: Nintedanib for treating fibrosing interstitial lung disease in people 6 to 17 years (TERMINATED APPRAISAL)
NICE TA347: Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer
NICE TA379: Nintedanib for treating idiopathic pulmonary fibrosis
NICE TA379: Nintedanib for treating idiopathic pulmonary fibrosis
NICE TA747: Nintedanib for treating progressive fibrosing interstitial lung diseases
NICE TA864: Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted